Laurie H. Glimcher, MD, named to Modern Healthcare’s Women Leaders Luminaries list

Posted date

Dana-Farber Cancer Institute is proud to announce that Laurie H. Glimcher, MD, president and CEO, has been recognized by Modern Healthcare as one of 2021’s Women Leaders Luminaries. The list includes executives whose careers have been defined by reshaping the industry who are also perennial figures in Modern Healthcare’s recognition programs.

The profiles of all the honorees are featured in the February 15 print issue of Modern Healthcare and at

The honorees are high achievers who are developing policy, leading change and guiding healthcare delivery improvement across the country. The award program recognizes women in leadership roles, spotlighting their administrative and professional accomplishments.

“Honorees of the 2021 Top 25 Women Leaders in Healthcare award program have a mission to combat the longstanding imbalance of gender equity at the top rungs of leadership by promoting and hiring more female executives. They serve as mentors and create workplaces that embrace diversity and inclusion. And last year, they did this all while guiding their organizations through a global pandemic,” said Modern Healthcare editor, Aurora Aguilar. “The honorees, chosen out of hundreds of nominations, represent passionate leadership and measurable results in bringing greater diversity to the C-suite and beyond. Because of the importance of these efforts in improving healthcare, we also are excited to announce that from now on we will be recognizing these outstanding leaders every year. Congratulations to the Class of 2021.”

“I’m deeply honored to be in this esteemed group of top women leaders. It is especially meaningful as the designation highlights being a mentor and creating a workplace that embraces inclusion and diversity -- ideals which have been a long-held priority of mine,” said Glimcher.

Related Doctors and Researchers

Media Contacts

If you are a journalist and have a question about this story, please call 617-632-4090 and ask to speak to a member of the media team, or email

The Media Team cannot respond to patient inquiries. For more information, please see Contact Us.